MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03228nam a22002537a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
ZW-GwMSU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20211201140851.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211201b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780444626356 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
rda |
| Language of cataloging |
eng |
| Transcribing agency |
MSULIB |
| Description conventions |
rda |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM302.5 |
| Item number |
SID |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Side effects of drugs Annual 35 |
| Remainder of title |
a worldwide yearly survey of new data in adverse drug reactions and interactions |
| Statement of responsibility, etc |
edited by J. K. Aronson |
| 264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Name of producer, publisher, distributor, manufacturer |
Elsevier |
| Date of production, publication, distribution, manufacture, or copyright notice |
2014 |
| -- |
c2014 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
lxxxix, 1044 pages |
| Other physical details |
20 cm. |
| 336 ## - CONTENT TYPE |
|---|
| Source |
rdacontent |
| content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| source |
rdamedia |
| media type term |
unmediated |
| media type code |
n |
| 338 ## - CARRIER TYPE |
|---|
| source |
rdacarrier |
| carrier type term |
volume |
| carrier type code |
nc |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Central nervous system stimulants and drugs that suppress appetite Antidepressant drugs Lithium Drugs of abuse Hypnosedatives and anxiolytics Antipsychotic drugs Antiepileptic drugs Opioid analgesics and narcotic antagonists Anti-inflammatory and antipyretic analgesics and drugs used in gout General anesthetics and therapeutic gases Local anesthetics Neuromuscular blocking agents and skeletal muscle relaxants Drugs that affect autonomic functions or the extrapyramidal system Dermatological drugs, topical agents and cosmetics Antihistamines (H1 receptor antagonists) Drugs that act on the respiratory tract Positive inotropic drugs and drugs used in dysrhythmias Beta-adrenoceptor antagonists and antianginal drugs Drugs acting on the cerebral and peripheral circulations Antihypertensive drugs Diuretics Metals Metal antagonists Antiseptic drugs and disinfectants Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines Miscellaneous antibacterial drugs Antifungal drugs Antiprotozoal Drugs Antiviral drugs Drugs used in tuberculosis and leprosy Antihelminthic drugs Vaccines Blood, blood components, plasma and plasma products Vitamins, intravenous solutions, and drugs and formulations used in nutrition Drugs affecting blood coagulation, fibrinolysis, and hemostasis Gastrointestinal drugs Drugs that act on the immune system: cytokines and monoclonal antibodies Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs Corticotrophins, corticosteroids, and prostaglandins Sex hormones and related compounds, including hormonal contraceptives Thyroid hormones, iodine, and antithyroid drugs Insulin, other hypoglycemic drugs, and glucagon Miscellaneous hormones Drugs that affect lipid metabolism Cytostatic and cytotoxic drugs Radiological contrast agents Drugs used in ocular treatment Treatments used in complementary and alternative medicine Miscellaneous drugs, materials, medical devices and techniques Medication errors |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Offers clinicians and medical investigators with a survey of data and trends in the area of Adverse Drug Reactions and Interactions. This book covers such topics as: epidemiology of the use of ecstasy, paracetamol and the risk of asthma, interactions of herbal medicines with warfarin, and Tyrosine kinase inhibitors. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Side effects |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aronson J. K. |
| Relator term |
editor - MA, DPhil, MBChB, FRCP, FBPharm |
| -- |
University of Oxford. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
Book |